Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.2708
-0.0302 (-10.03%)
At close: May 20, 2025, 4:00 PM
0.5697
+0.2989 (110.38%)
After-hours: May 20, 2025, 7:59 PM EDT
Biodesix Revenue
Biodesix had revenue of $17.96M in the quarter ending March 31, 2025, with 21.19% growth. This brings the company's revenue in the last twelve months to $74.46M, up 35.76% year-over-year. In the year 2024, Biodesix had annual revenue of $71.32M with 45.30% growth.
Revenue (ttm)
$74.46M
Revenue Growth
+35.76%
P/S Ratio
0.52
Revenue / Employee
$272,758
Employees
273
Market Cap
39.53M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
BDSX News
- 5 days ago - Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS - GlobeNewsWire
- 6 days ago - Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award - GlobeNewsWire
- 7 days ago - Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Biodesix Announces First Quarter 2025 Results and Highlights - GlobeNewsWire
- 21 days ago - Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire
- 27 days ago - Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types - GlobeNewsWire
- 2 months ago - Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewsWire